NCT06205251

Brief Summary

The purpose of this research is to study the feasibility of a specific training program for the breathing muscles (inspiratory muscle training) and the effects on how breathing is regulated during exercise in childhood cancer survivors.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 3, 2024

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 12, 2024

Completed
2 months until next milestone

Study Start

First participant enrolled

March 15, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 7, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 7, 2025

Completed
Last Updated

March 30, 2026

Status Verified

March 1, 2026

Enrollment Period

10 months

First QC Date

January 3, 2024

Last Update Submit

March 25, 2026

Conditions

Keywords

Inspiratory Muscle TrainingDiaphragmControl of BreathingMuscle dysfunctionDyspnea

Outcome Measures

Primary Outcomes (2)

  • Percent completion

    Percentage of enrolled participants who complete the 6-week inspiratory muscle training protocol

    6 weeks

  • Adherence to treatment protocol

    Number of sets and repetitions of training breaths completed during the 6-week inspiratory muscle training protocol

    6 weeks

Secondary Outcomes (3)

  • Maximal inspiratory pressure (measured in cm H2O)

    6 weeks

  • Diaphragm thickness (measured in mm)

    6 weeks

  • Exercise ventilation

    6 weeks

Other Outcomes (1)

  • 6-minute walk test distance (measured in m)

    6 weeks

Study Arms (1)

Inspiratory Muscle Training (IMT)

EXPERIMENTAL

Participants will be asked to perform inspiratory muscle training (breathing exercise) 5 days per week for 6 weeks at home.

Device: POWERbreathe Plus IMT

Interventions

Inspiratory muscle training will be performed using the POWERbreathe Plus IMT (POWERbreathe International Ltd., Warwickshire, UK), a commercially available inspiratory pressure threshold device. In this type of training, airflow is occluded until the generated inspiratory pressure reaches the predetermined threshold, which can be set at increments of 8 cm H2O. During the first week of training, the target intensity will be set at 50% of baseline maximal inspiratory pressure (MIP.) During the second week, the target intensity will be set at 60% of baseline MIP. Beginning at the third week and for the remainder of the training program, the target intensity will be set at 75% of the participant's baseline MIP. The target volume will be 5 sets of 6 breaths per day (total of 30 breaths per day), separated by 1-minute rest breaks between sets. The frequency of training will be 5 days per week, for a duration of 6 weeks.

Inspiratory Muscle Training (IMT)

Eligibility Criteria

Age6 Years - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Completed medical treatment (chemotherapy, chemotherapy/surgery, chemotherapy/radiation or any combination of cancer treatment) for any type of cancer, except for cancer of the central nervous system, at least 1 year ago

You may not qualify if:

  • History of neuromuscular, cardiac, or pulmonary disease prior to the diagnosis of cancer
  • Recent injury or condition (less than 6 months ago) that precludes strength testing or walking
  • Dyspnea with minimal activity (4 on the modified Medical Research Council Dyspnea Scale)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Maryland, Baltimore

Baltimore, Maryland, 21201, United States

Location

MeSH Terms

Conditions

NeoplasmsDyspnea

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Simon Ho

    University of Maryland, Baltimore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

January 3, 2024

First Posted

January 12, 2024

Study Start

March 15, 2024

Primary Completion

January 7, 2025

Study Completion

January 7, 2025

Last Updated

March 30, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations